ZURLLO Trademark

Trademark Overview

On Tuesday, March 1, 2016, a trademark application was filed for ZURLLO with the United States Patent and Trademark Office. The USPTO has given the ZURLLO trademark a serial number of 86924527. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 26, 2024. This trademark is owned by AstraZeneca AB. The ZURLLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
zurllo

General Information

Serial Number86924527
Word MarkZURLLO
Filing DateTuesday, March 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 26, 2024
Registration Number5239247
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, January 26, 2024CANCELLED SEC. 8 (6-YR)
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Friday, June 2, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, May 11, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 31, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 11, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 7, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 13, 2016ASSIGNED TO LIE
Friday, August 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 28, 2016NON-FINAL ACTION E-MAILED
Monday, March 28, 2016NON-FINAL ACTION WRITTEN
Monday, March 21, 2016ASSIGNED TO EXAMINER
Friday, March 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 4, 2016NEW APPLICATION ENTERED

Related Keywords

zurllo diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal